CYBB and COVID-19: NADPH oxidase-2 (NOX-2) is overexpressed in hospitalized COVID-19 patients, resulting in increased oxidative stress, according to Violi et al. Other authors have found that blocking NOX-2 enhances disease phenotypes in macrophages by reducing oxidative stress, which is consistent with these findings [3].